Cardiac function in renovascular hypertensive patients with and without renal dysfunction

American Journal of Hypertension

Volumn 27, Issue 3, 2014, Pages 445-453

  Khangura, Kirandeep K ^a   Eirin, Alfonso ^a   Kane, Garvan C ^a   Misra, Sanjay ^a   Textor, Stephen C ^a   Lerman, Amir ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

blood pressure; diastolic function; hypertension; left ventricular hypertrophy; renovascular hypertension

Indexed keywords

BLOOD PRESSURE; DIASTOLIC FUNCTION; HYPERTENSION; LEFT VENTRICULAR HYPERTROPHY; RENOVASCULAR HYPERTENSION.;

AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CREATININE; DIASTOLE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; HYPERTENSION, RENOVASCULAR; HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR; KAPLAN-MEIER ESTIMATE; KIDNEY; MALE; MIDDLE AGED; MINNESOTA; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; SYSTOLE; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84894252612     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt203     Document Type: Article

References (42)

1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-838.
2. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
3. Mancia G. Blood pressure reduction and cardiovascular outcomes: past, present, and future. Am J Cardiol 2007; 100:3J-9J.
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
5. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000; 35:580-586.
6. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC, Jr., Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease)-summary of recommendations. J Vasc Interv Radiol 2006; 17:1383-1397; quiz 1398.
7. Przewlocki T, Kablak-Ziembicka A, Tracz W, Kopec G, Rubis P, Pasowicz M, Musialek P, Kostkiewicz M, Kozanecki A, Stompor T, Sulowicz W, Sokolowski A. Prevalence and prediction of renal artery stenosis in patients with coronary and supraaortic artery atherosclerotic disease. Nephrol Dial Transplant 2008; 23:580-585.
8. Wang Y, Ho DS, Chen WH, Wang YQ, Lam WF, Shen ZJ, Lu CZ, Chui M. Prevalence and predictors of renal artery stenosis in chinese patients with coronary artery disease. Intern Med J 2003; 33:280-285.
9. Jean WJ, al-Bitar I, Zwicke DL, Port SC, Schmidt DH, Bajwa TK. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn 1994; 32:8-10.
10. Przewlocki T, Kablak-Ziembicka A, Tracz W, Kozanecki A, Kopec G, Rubis P, Kostkiewicz M, Roslawiecka A, Rzeznik D, Stompor T. Renal artery stenosis in patients with coronary artery disease. Kardiol Pol 2008; 66:856-862; discussion 863-854.
11. Textor SC. Current approaches to renovascular hypertension. Med Clin North Am 2009; 93:717-732.
12. Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen SC, Ishani A, Collins AJ, Foley RN. Atherosclerotic renovascular disease in united states patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005; 68:293-301.
13. Kane GC, Xu N, Mistrik E, Roubicek T, Stanson AW, Garovic VD. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant 2010; 25:813-820.
14. Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA. Left ventricular morphology and function in patients with atherosclerotic renovascular disease. J Am Soc Nephrol 2005; 16:2746-2753.
15. Ghanami RJ, Rana H, Craven TE, Hoyle J, Edwards MS, Hansen KJ. Diastolic function predicts survival after renal revascularization. J Vasc Surg 2011; 54:1720-1726.
16. Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA. Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease. QJM 2009; 102:695-704.
17. Urbieta-Caceres VH, Zhu XY, Jordan KL, Tang H, Textor K, Lerman A, Lerman LO. Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease. Atherosclerosis 2012; 221:350-358.
18. Eirin A, Zhu XY, Krier JD, Tang H, Jordan KL, Grande JP, Lerman A, Textor SC, Lerman LO. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 2012; 30:1030-1041.
19. Murphy TP, Cooper CJ, Dworkin LD, Henrich WL, Rundback JH, Matsumoto AH, Jamerson KA, D'Agostino RB. The cardiovascular outcomes with renal atherosclerotic lesions (coral) study: rationale and methods. J Vasc Interv Radiol 2005; 16:1295-1300.
20. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10:165-193.
21. Moller JE, Pellikka PA, Hillis GS, Oh JK. Prognostic importance of diastolic function and filling pressure in patients with acute myocardial infarction, Circulation 2006; 114:438-444.
22. Gilman G, Nelson TA, Hansen WH, Khandheria BK, Ommen SR. Diastolic function: a sonographer's approach to the essential echocardiographic measurements of left ventricular diastolic function. J Am Soc Echocardiogr 2007; 20:199-209.
23. Corriere MA, Hoyle JR, Craven TE, D'Agostino RB Jr, Edwards MS, Moore PS, Hansen KJ. Changes in left ventricular structure and function following renal artery revascularization. Ann Vasc Surg 2010; 24:80-84.
24. Eirin A, Gloviczki ML, Tang H, Rule AD, Woollard JR, Lerman A, Textor SC, Lerman LO. Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin. Nephrol Dial Transplant 2012; 27:4153-4161.
25. Zhu XY, Daghini E, Rodriguez-Porcel M, Chade AR, Napoli C, Lerman A, Lerman LO. Redox-sensitive myocardial remodeling and dysfunction in swine diet-induced experimental hypercholesterolemia. Atherosclerosis 2007; 193:62-69.
26. Masiha S, Sundstrom J, Lind L. Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women. J Hum Hypertens 2013; 27:13-17.
27. Talib A, Nakagawa N, Saito E, Matsuki M, Kobayashi M, Akasaka K, Hirayama T, Ishida H, Sato N, Hasebe N. The balance of fetuin- A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients. Hypertens Res 2012; 35:426-433.
28. Zhang X, Eirin A, Lerman A, Lerman LO. Osteopontin: an emerging therapeutic target in uremic vascular disease. Cardiovas Res 2013; 98:332-333.
29. Kawarada O, Yokoi Y, Morioka N, Shiotani S, Higashimori A. Cardiac benefits of renal artery stenting. EuroIntervention 2010; 6:485-491.
30. Rzeznik D, Przewlocki T, Kablak-Ziembicka A, Kozanecki A, Roslawiecka A, Lach J, Tracz W, Podolec P. Effect of renal artery revascularization on left ventricular hypertrophy, diastolic function, blood pressure, and the one-year outcome. J Vasc Surg 2011; 53:692-697.
31. Emans ME, van der Putten K, Velthuis BK, de Vries JJ, Cramer MJ, America YG, Hillege HL, Meiss L, Doevendans PA, Braam B, Gaillard CA. Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging. BMC Cardiovasc Disord 2012; 12:76.
32. Cherr GS, Hansen KJ, Craven TE, Edwards MS, Ligush J Jr, Levy PJ, Freedman BI, Dean RH. Surgical management of atherosclerotic renovascular disease. J Vasc Surg 2002; 35:236-245.
33. Nardi E, Palermo A, Mule G, Cusimano P, Cottone S, Cerasola G. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 2009; 27:633-641.
34. Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Prevalence of leftventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens 2012; 26:343-349.
35. Ulasi II, Arodiwe EB, Ijoma CK. Left ventricular hypertrophy in african black patients with chronic renal failure at first evaluation. Ethn Dis 2006; 16:859-864.
36. Fox ER, Taylor J, Taylor H, Han H, Samdarshi T, Arnett D, Myerson M. Left ventricular geometric patterns in the Jackson cohort of the Atherosclerotic Risk in Communities (ARIC) study: clinical correlates and influences on systolic and diastolic dysfunction. Am Heart J 2007; 153:238-244.
37. Bayauli MP, Lepira FB, Kayembe PK, M'Buyamba-Kabangu JR. Left ventricular hypertrophy and geometry in type 2 diabetes patients with chronic kidney disease. An echocardiographic study. Cardiovasc J Afr 2012; 23:73-77.
38. Sambi RS, Gaur AK, Hotchandani R, Aggarwal KK, Kaur S, Gupta M, Jain S, Krishna CK, Chopra HK, Anand V, Srivastava S, Gupta R, Parashar SK. Patterns of left ventricular hypertrophy in chronic kidney disease: an echocardiographic evaluation. Indian Heart J Teach Ser 2011; 63:259-268.
39. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56:56-64.
40. Chahal NS, Lim TK, Jain P, Chambers JC, Kooner JS, Senior R. New insights into the relationship of left ventricular geometry and left ventricular mass with cardiac function: a population study of hypertensive subjects. Eur Heart J 2010; 31:588-594.
41. Devereux RB, Bella JN, Palmieri V, Oberman A, Kitzman DW, Hopkins PN, Rao DC, Morgan D, Paranicas M, Fishman D, Arnett DK. Left ventricular systolic dysfunction in a biracial sample of hypertensive adults: the Hypertension Genetic Epidemiology Network (HYPERGEN) study. Hypertension 2001; 38:417-423.
42. Wachtell K, Rokkedal J, Bella JN, Aalto T, Dahlof B, Smith G, Roman MJ, Ibsen H, Aurigemma GP, Devereux RB. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (the Life Study). Losartan intervention for endpoint. Am J Cardiol 2001; 87:54-60.